These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19591190)

  • 1. Retro-enantio N-methylated peptides as beta-amyloid aggregation inhibitors.
    Grillo-Bosch D; Carulla N; Cruz M; Sánchez L; Pujol-Pina R; Madurga S; Rabanal F; Giralt E
    ChemMedChem; 2009 Sep; 4(9):1488-94. PubMed ID: 19591190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
    Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
    Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
    Matharu B; El-Agnaf O; Razvi A; Austen BM
    Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement of aggregation propensity of Alzheimer amyloid peptides for neuronal cell surface binding.
    Bateman DA; McLaurin J; Chakrabartty A
    BMC Neurosci; 2007 May; 8():29. PubMed ID: 17475015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide inhibitors of beta-amyloid aggregation.
    Doig AJ
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):533-9. PubMed ID: 17786851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of protein aggregation and toxicity.
    Amijee H; Madine J; Middleton DA; Doig AJ
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):692-6. PubMed ID: 19614577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Branched KLVFF tetramers strongly potentiate inhibition of beta-amyloid aggregation.
    Chafekar SM; Malda H; Merkx M; Meijer EW; Viertl D; Lashuel HA; Baas F; Scheper W
    Chembiochem; 2007 Oct; 8(15):1857-64. PubMed ID: 17763487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42.
    Liu R; Barkhordarian H; Emadi S; Park CB; Sierks MR
    Neurobiol Dis; 2005 Oct; 20(1):74-81. PubMed ID: 16137568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationally designed dehydroalanine (DeltaAla)-containing peptides inhibit amyloid-beta (Abeta) peptide aggregation.
    Rangachari V; Davey ZS; Healy B; Moore BD; Sonoda LK; Cusack B; Maharvi GM; Fauq AH; Rosenberry TL
    Biopolymers; 2009 Jun; 91(6):456-65. PubMed ID: 19189374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abeta40 protects non-toxic Abeta42 monomer from aggregation.
    Yan Y; Wang C
    J Mol Biol; 2007 Jun; 369(4):909-16. PubMed ID: 17481654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eight-residue Abeta peptides inhibit the aggregation and enzymatic activity of Abeta42.
    Matsunaga Y; Fujii A; Awasthi A; Yokotani J; Takakura T; Yamada T
    Regul Pept; 2004 Aug; 120(1-3):227-36. PubMed ID: 15177941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse models.
    van Groen T; Kadish I; Wiesehan K; Funke SA; Willbold D
    ChemMedChem; 2009 Feb; 4(2):276-82. PubMed ID: 19072935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of peptides binding to the amyloid b-protein reveals potential inhibitors of amyloid formation.
    Schwarzman AL; Tsiper M; Gregori L; Goldgaber D; Frakowiak J; Mazur-Kolecka B; Taraskina A; Pchelina S; Vitek MP
    Amyloid; 2005 Dec; 12(4):199-209. PubMed ID: 16399644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide.
    Austen BM; Paleologou KE; Ali SA; Qureshi MM; Allsop D; El-Agnaf OM
    Biochemistry; 2008 Feb; 47(7):1984-92. PubMed ID: 18189413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transthyretin inhibition of amyloid beta aggregation and toxicity.
    Giunta S; Valli MB; Galeazzi R; Fattoretti P; Corder EH; Galeazzi L
    Clin Biochem; 2005 Dec; 38(12):1112-9. PubMed ID: 16183049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galantamine inhibits beta-amyloid aggregation and cytotoxicity.
    Matharu B; Gibson G; Parsons R; Huckerby TN; Moore SA; Cooper LJ; Millichamp R; Allsop D; Austen B
    J Neurol Sci; 2009 May; 280(1-2):49-58. PubMed ID: 19249060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both the D-(+) and L-(-) enantiomers of nicotine inhibit Abeta aggregation and cytotoxicity.
    Moore SA; Huckerby TN; Gibson GL; Fullwood NJ; Turnbull S; Tabner BJ; El-Agnaf OM; Allsop D
    Biochemistry; 2004 Jan; 43(3):819-26. PubMed ID: 14730987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inflammation-sensitive protein alpha 1-anti-chymotrypsin neutralizes fibrillar aggregation and cytotoxicity of the beta-amyloid peptide more effectively than alpha 1-antitrypsin.
    Giunta S; Galeazzi R; Marcellini M; Corder EH; Galeazzi L
    Clin Biochem; 2007 Aug; 40(12):887-92. PubMed ID: 17512513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.